Light relief: Does LLLT help dry eye disease?

2 August 2023

Summer 2023

Interest is growing in the use of low-level light therapy to remedy dry eye disease. Adrian O’Dowd investigates the evidence behind the treatment.

Dry eye disease can cause symptoms of discomfort, visual disturbance and tear film instability, with potential damage to the ocular surface (Vehof et al, 2014). One treatment is intense pulsed light (IPL) therapy, which has been shown to be effective in treating patients with meibomian gland dysfunction (MGD) – the most common cause of dry eye (Thomas, 2021). An emerging treatment is low-level light therapy (LLLT), and alongside IPL is classed as a form of photobiomodulation.

Sign in to continue

Related further reading

College calls for glaucoma care shift by fully unlocking safe and effective primary care capacity

Glaucoma is the second leading cause of irreversible sight loss in the UK and affects over one million people, which is predicted to rise by 100,000 cases to 1.145 million people by 2030*.

College responds to the publication of the Neighbourhood Health Framework for England

The government has progressed its commitment to moving more care from hospitals to communities.

College publishes first issue of Ophthalmic and Physiological Optics (OPO) with Springer Nature

The College of Optometrists has published its first issue of Ophthalmic and Physiological Optics (OPO), its flagship international and interdisciplinary research journal for contemporary vision science and optometry, with its new publishing partner Springer Nature this month.